Terry Harville
Sourced from institutional research profiles (UAMS TRI or ARA).
Professor
Faculty Researcher
Pathology, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Terry Harville's research focuses on understanding the mechanisms of disease, particularly in relation to cancer and infectious agents. His work involves investigating the genetic and molecular underpinnings of diseases to identify potential therapeutic targets. Harville has published extensively in peer-reviewed journals, contributing to the scientific understanding of cellular processes and disease progression. His research activities are situated within the pathology department at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 15
- Publications: 102
- Citations: 2,825
Selected Publications
-
Evaluation of LABType® CWD versus XR beads for HLA typing: implications for transition in clinical workflow (2025)
-
Virtual crossmatch compatible, with unexpected fluorescence cytometric crossmatch positive, may be safe to proceed with transplantation under certain circumstances (2025)
-
How much intravenous immunoglobulin and how often to infuse is required to treat active viral respiratory infections in immunocompromised patients? (2024)
-
Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients (2024)
-
Virtual crossmatch (VXM) by the numbers (2024)
-
DNA structural features and variability of complete MHC locus sequences (2024)
-
Review 1: "Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19" (2024)
-
Reviews of "Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19" (2024)
-
HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies (2024)
-
P504 Differentiating among allele-specific antibodies is important for a successful heart transplantation (2023)
-
P513 Towards automated epitope analysis during virtual crossmatch (2023)
-
P526 CREG associations and epitope analyses should not be overlooked when performing virtual crossmatch (2023)
-
Successful Treatment with High-Dose Immunoglobulin of a Complicated Patient with Catatonia and Central Nervous System Autoantibodies (2023)
-
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study (2022)
-
Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity (2022)
Collaboration Network
Top Collaborators
- P526 CREG associations and epitope analyses should not be overlooked when performing virtual crossmatch
- P504 Differentiating among allele-specific antibodies is important for a successful heart transplantation
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- Virtual crossmatch (VXM) by the numbers
- Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients
- Virtual crossmatch compatible, with unexpected fluorescence cytometric crossmatch positive, may be safe to proceed with transplantation under certain circumstances
- Evaluation of LABType® CWD versus XR beads for HLA typing: implications for transition in clinical workflow
- Impact of Immunodeficiency on Multiple Sclerosis Patients Receiving Rituximab
- The Impact of Immunodeficiency on Patients Receiving Immunologic-Based Multiple Sclerosis Therapies
- Impact of Immunodeficiency on Multiple Sclerosis Patients Receiving Rituximab
- The Impact of Immunodeficiency on Patients Receiving Immunologic-Based Multiple Sclerosis Therapies
- Development of ACE2 autoantibodies after SARS-CoV-2 infection
- Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
- Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity
- Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity
Similar Researchers
Based on overlapping research topics